Drug Availability

HPS Pharmacies wish to give notice that Pfizer Australia is experiencing a supply interruption for DBL™ Pethidine Hydrochloride Injection BP as follows:

DBL™ Pethidine Hydrochloride Injection BP
Pethidine Hydrochloride 100mg/2mL
ARTG 107387

DBL™ Pethidine Hydrochloride Injection BP
Pethidine Hydrochloride 50mg/1mL
ARTG 107386

Normal supplies of DBL™ Pethidine Hydrochloride 100mg/2mL and 50mg/1mL are expected to resume by mid-August 2019.

An internationally registered brand of pethidine 50mg/1mL ampoules has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that Section 19A alternatives are subject to a longer lead time and different pricing as they must be sourced internationally.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer Australia on 1800 629 921 or your pharmacist at HPS Pharmacies.